tPA (Tissue Plasminogen Activator) Contraindications for Ischemic Stroke

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۲۰ • واحد: years

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
eligibility
—امتیاز
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Eligible—
  • Absolute Contraindication—
  • Relative Contraindication—
Direct Clinical Answer

The tPA (Tissue Plasminogen Activator) Contraindications for Ischemic Stroke calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include symptom onset time. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Evaluates eligibility and contraindications for thrombolytic therapy with IV tPA in acute ischemic stroke patients. Reviews absolute and relative contraindications based on AHA/ASA guidelines.

Clinical Indication

The tPA (Tissue Plasminogen Activator) Contraindications for Ischemic Stroke is indicated for bedside clinical practice to support Evaluates eligibility and contraindications for thrombolytic therapy with IV tPA in acute ischemic stroke patients. Reviews absolute and relative contraindications based on AHA/ASA guidelines.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis. Clinical exclusion: This tool evaluates contraindications for IV tPA (alteplase) in acute ischemic stroke.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: Blood pressure must be <185/110 mmHg before and during treatment.

Formula & Variables:

Assessment of absolute and relative contraindications based on AHA/ASA guidelines

Input Parameters

NameTypeRequiredDescription
symptom_onset_timestringYesTime since symptom onset
ageintegerYesPatient age in years(years)
ischemic_stroke_within_3_monthsstringYesHistory of ischemic stroke within 3 months
severe_head_trauma_within_3_monthsstringYesSevere head trauma within 3 months
intracranial_surgery_within_3_monthsstringYesIntracranial/intraspinal surgery within 3 months
history_intracranial_hemorrhagestringYesHistory of intracranial hemorrhage
subarachnoid_hemorrhagestringYesSymptoms suggestive of subarachnoid hemorrhage
gi_malignancy_bleeding_21_daysstringYesGI malignancy or GI bleeding within 21 days
coagulopathystringYesBleeding diathesis or coagulopathy
inr_greater_1_7stringYesINR >1.7 or PT >15 seconds
aptt_greater_40stringYesaPTT >40 seconds
platelet_count_less_100kstringYesPlatelet count <100,000/mm³
tc_48h_lmwhstringYesTreatment dose LMWH within 24 hours
thrombin_factor_xa_inhibitorsstringYesCurrent use of direct thrombin or factor Xa inhibitors
glucose_less_50stringYesBlood glucose <50 mg/dL
ct_ichstringYesCT demonstrates intracranial hemorrhage
ct_hypodensity_one_thirdstringYesCT shows multilobar infarction (hypodensity >1/3 cerebral hemisphere)
sbp_greater_185stringYesSystolic BP >185 mmHg
dbp_greater_110stringYesDiastolic BP >110 mmHg
infective_endocarditisstringYesActive infective endocarditis
aortic_dissectionstringYesKnown or suspected aortic arch dissection
neoplasm_increased_bleedingstringYesIntracranial neoplasm with increased bleeding risk
minor_symptomsstringNoOnly minor and non-disabling stroke symptoms
symptoms_clearingstringNoSymptoms clearing spontaneously
pregnancystringNoPregnancy
seizure_at_onsetstringNoSeizure at onset with postictal neurological impairments
major_surgery_14_daysstringNoMajor surgery or serious trauma within 14 days
gi_hemorrhage_21_daysstringNoRecent GI or urinary tract hemorrhage within 21 days
mi_within_3_monthsstringNoRecent acute myocardial infarction within 3 months

Score Interpretation & Guidance

RangeStageDescription
—EligibleNo contraindications identified
—Absolute ContraindicationOne or more absolute contraindications present
—Relative ContraindicationOne or more relative contraindications present

Evidence-Based References (EBM)

  • Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-e418.
  • Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29.
  • Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Mar;44(3):870-947.

Related calculators